Variant report
Variant | esv3412093 |
---|---|
Chromosome Location | chr3:51895209-51895471 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | ATF1 | chr3:51894914-51895263 | K562 | blood: | n/a | n/a |
2 | EBF1 | chr3:51895042-51895631 | GM12878 | blood: | n/a | n/a |
3 | EBF1 | chr3:51895021-51895561 | GM12878 | blood: | n/a | n/a |
4 | EBF1 | chr3:51895013-51895795 | GM12878 | blood: | n/a | n/a |
5 | MAX | chr3:51895074-51895399 | NB4 | blood: | n/a | chr3:51895269-51895279 |
6 | RUNX3 | chr3:51895060-51895383 | GM12878 | blood: | n/a | n/a |
7 | RUNX3 | chr3:51895028-51895415 | GM12878 | blood: | n/a | n/a |
8 | SPI1 | chr3:51895403-51895515 | K562 | blood: | n/a | n/a |
9 | TAL1 | chr3:51894745-51895360 | K562 | blood: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
IQCF2 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537733670 | chr3:51895222-51895223 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs558915158 | chr3:51895223-51895224 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs577019149 | chr3:51895259-51895260 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs2007607 | chr3:51895260-51895261 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs140513692 | chr3:51895297-51895298 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs56131900 | chr3:51895329-51895330 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs2311061 | chr3:51895330-51895331 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs143696125 | chr3:51895340-51895341 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs141020148 | chr3:51895341-51895342 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs541828056 | chr3:51895354-51895355 | Enhancers Bivalent Enhancer | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs563614313 | chr3:51895408-51895409 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs575481378 | chr3:51895426-51895427 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs376234789 | chr3:51895439-51895440 | Enhancers Flanking Active TSS | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 21785460 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Bladder cancer | 21909424 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Septo-optic dysplasia | 21572526 | CNVD |
Biliary cancer | 19435499 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Ventriculomegaly | 21325761 | CNVD |
Breast cancer | 16608533 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:51894800-51895400 | Bivalent Enhancer | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
2 | chr3:51894800-51895800 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr3:51895000-51895800 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr3:51895200-51895400 | Enhancers | GM12878-XiMat | blood |
5 | chr3:51895400-51895800 | Flanking Active TSS | GM12878-XiMat | blood |